By Nature SRL
By Nature reported total assets of 154,196 € at the end of the 2025 financial year (annual accounts filed with the NBB on 14 Aug 2026).
The score of By Nature shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +64 % Total assets +78 %
Accounts of the company itself (not consolidated).
The full file covers 10 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
By Nature's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 14 Aug 2026
- Year ended 31 Dec 2024filed on 07 Aug 2025
- Year ended 31 Dec 2023filed on 28 Aug 2024
- Year ended 31 Dec 2022filed on 28 Aug 2023
- Year ended 31 Dec 2021filed on 30 Jun 2022
By Nature's financial analysis
- Solvency58.2%sector median: 37.8%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of By Nature
By Nature's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0892.541.738
- VAT number
- BE0892541738
- Peppol
- Registered · 0208:0892541738 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 04 Oct 2007
- Registered office
- 1210 Saint-Josse-ten-Noode
- Latest accounts
- 2025 · filed on 14 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
By Nature (SRL) has been based in Saint-Josse-ten-Noode since 2007, active in: retail sale of pharmaceutical products. For 2025, it reports a net loss of 1,781 € and equity of 89,692 €; its revenue is not published. Its solvency stands at 58.2%, above the median of its sector (37.8%).
Guide: Reading Belgian SME accounts: the five figures that count →
Companies similar to By Nature
Companies in the same business, of comparable size and area, outside its group.
- Pharmacie de Bousval Retail sale of pharmaceutical products Genappe · balance sheet 139,616 €
- Jovaphar Retail sale of pharmaceutical products Middelkerke · balance sheet 154,803 €
- Clement Pharma Services Retail sale of pharmaceutical products Meise · balance sheet 151,301 €
- Monsoon Retail sale of pharmaceutical products Ghent · balance sheet 157,805 €
- Un Coquelicot Orange Retail sale of pharmaceutical products Courcelles · balance sheet 150,628 €
- Apotheek Els De Smedt Retail sale of pharmaceutical products Beveren-Kruibeke-Zwijndrecht · balance sheet 157,911 €
- X - Pharma Retail sale of pharmaceutical products Verviers · balance sheet 150,150 €
- Phamalimo Retail sale of pharmaceutical products Seneffe · balance sheet 159,435 €
Frequently asked questions about By Nature
What is the revenue of By Nature?
By Nature files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of By Nature?
In Belgium, the VAT number is the company number prefixed with BE: BE0892541738 for By Nature, if the company is VAT-registered. Its company number (CBE) is 0892.541.738.
Where is the registered office of By Nature?
According to the CBE register, the registered office of By Nature is in 1210 Saint-Josse-ten-Noode.
What is the equity of By Nature?
At the close of the 2025 financial year, the equity of By Nature amounts to 89,692 €, a solvency of 58.2% of total assets.
Who manages By Nature?
The register lists 2 active mandates at By Nature. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of By Nature
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →